CANNAGROW HOLDINGS (OTCMKTS:CGRW) recently announced submission of the Land Use Application for its Colorado project. The company seeks approval from the Planning Commission and then by the County Commissioners for this Application. Once approved, CANNAGROW will begin the build out in five phases, encompassing 30,000 sq. ft. of growing area. The build out will include 16 Hoop-houses, a Head-house and state-of-the art greenhouse facility.
Will CGRW continue on its latest trend? Get the free report!
The Colorado project will also require infrastructure improvements like a commercial well, water lines, sewer system, lighting, storage tanks, security fencing and roadways. CannaGrow is working as the Representative for NuGro Industries to bring the project from the planning to a working state-of-the-art Growing Facility. The completion of this project will allow the company to begin revenue streaming from licensed Growers.
Delmar Janovec, CEO of CANNAGROW HOLDINGS (OTCMKTS:CGRW), said that the landowner and developer of these facilities, NuGro Industries submitted the Land Use Application to the Huerfano County Planning Department. The application will go to the Huerfano County Planning Commission on January 7, 2015. The Commission will then review the Application and other prerequisites for the project such as Site Plans, Phasing Plans and various exhibits.
The state of Colorado is among those states which have legalized medical marijuana. The state is operating the Medical Marijuana Registry program since June 2001 and more than 278,300 new patient applications have been received to date. Among those 65% of approved applicants are male and approximately 44% of total patients belong to 21 to 40 years age group. Nearly 60% patients are residents of the Denver-metro area. More than 800 difference physicians have registered for current patients in the State.
In the medical marijuana sector, CannaGrow competes with the likes of Tauriga Sciences, Inc. (OTCMKTS:TAUG), Nuvilex, Inc. (OTCMKTS:NVLX) and GB Sciences” (OTCQB:GBLX), among others.